Bajaj Finance, Havells & more: Top stocks to watch out for on March 6

Untitled design 30.jpg


Bajaj Finance, Havells & more: Top stocks to watch out for on March 6

Jefferies has a buy on L&T with a reduced target price of Rs 4,500 from Rs 4,715 earlier. Analysts said global engineering & construction companies with West Asia exposure, including L&T, are down between 10-24% since the Iran-US-Israel conflict began. 37% of L&T’s order book is from the region, with Saudi Arabia at a lion’s share of 75%+. A month of no work would likely impact FY26 earnings per share by 6-8%. Assuming normalcy returns over time in West Asia, L&T should recover most of its share price losses between order flow growth, margin stability and five-year strategy plan that is due to be unveiled in May 2026.BoFA Securities has a buy on AB Capital with the target price at Rs 380. Analysts said the company is witnessing strong growth tailwinds in lending, with the MSME expansion being supported by government measures while in the housing finance sector, retail penetration is improving. The company has a focus on market share. In the AMC, moderation is seen in equity market share losses, and in insurance, there’s strong premium growth. The company targets 2.5%/2-2.2% return on assets (RoA) for NBFC/HFC business in the coming few quarters, and the delivery towards which could support valuation re-rating.Goldman Sachs has a sell rating on Sun Pharmaceuticals with the target price at Rs 1,550. Analysts attended the company’s corporate day. They said that for the company innovative medicines remain a key growth driver. Emerging markets and the rest of the world (ROW) showed sustained outperformance. In India, the company aspires to grow in line with or slightly ahead of the market, though current market share gains (30bps in Q3) may normalize. The company has minimal exposure to the West Asian markets while its Israel operations have continued uninterrupted despite ongoing conflicts. On its M&A strategy, the focus remains on profitable growth, with innovative medicines as top priority, followed by emerging market assets. No explicit size cap, but financial discipline will be maintained. On the GLP-1 launches, the company’s management expects significant competition and pricing uncertainty, and market dynamics will determine eventual pricing. No guidance on margin impact.Kotak Institutional Equities has an add rating on Bajaj Finance with the target price at Rs 1,100. Analysts said that the investors’ myopic focus on near-term trends and credit metrics risk missing a structural transformation that is underway at Bajaj Finance, where Fin-AI is already moving from experimentation to measurable business outcomes. This mirrors broader ‘quarterly trap’, where investors extrapolate near-term trends while underweighting more durable shifts in business models. Analysts remain assertive on Bajaj Finance’s ability to sustain high growth and return on equity despite a large balance sheet.Motilal Oswal Securities maintained its neutral rating on Havells India with the target price at Rs 1,490. Analysts said short-term softness and medium-term recovery are expected. There is strong demand in the cables & wires segment with near-term margin pressure. In the Lloyd division, inventory normalisation is underway but demand recovery is awaited. In its electrical consumer durables, switchgear and lighting divisions, pricing actions are supporting margins amid mixed demand trends.(Disclaimer: Recommendations and views on the stock market, other asset classes or personal finance management tips given by experts are their own. These opinions do not represent the views of The Times of India)



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *